Phosphoenix
PrivateLast Round
Early Funding
Sep 16, 2026
Total Funding Raised
$4.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Phosphoenix operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was an Early Funding round in September 2026.
Phosphoenix is a MedTech company that develops brain-computer interface technology and visual prostheses to restore functional vision for blind individuals.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phosphoenix Comparables
Compare Phosphoenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReVision Implant | 92% | |
| Vivani Medical | 81% | |
| Neuralink | 76% |
For institutional investors. Book with your work email.
Phosphoenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 16, 2026 | ||||
| Convertible Debt | Apr 30, 2025 | ||||
| Grant | Jan 15, 2025 | ||||
| Seed | Dec 11, 2024 | ||||
| Pre Seed | Sep 22, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Phosphoenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| ROM InWest | Early Funding |
| Innovatiefonds Noord-Holland | Convertible Debt, Early Funding, Pre Seed |
| BioGeneration Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2026
$1.5M raised from BioGeneration Ventures and others.
- Aug 24, 2026
Grew 24% QoQ from 17 to 21 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 18, 2026
On Sep 16th '26, Phosphoenix completes a financing round with continued support from TTT Medtech Fund, FIRST Fund, and Innovatiefonds Noord-Holland, plus new investment from ROM InWest, to prepare for its first-in-human clinical study and further develop its neurostimulation system.
- is_developingSep 18, 2026
On Sep 18th '26, Phosphoenix claims to be developing its neuroprosthetic system to address the unmet need for functional vision restoration by directly stimulating the brain’s lateral geniculate nucleus with a Fountain Probe containing more than 1,000 microelectrodes.
- attends_eventAug 17, 2026
Phosphoenix attends ICNCE 2026 in Germany in Jul '26, spending four days showcasing its work, gathering feedback, and connecting with the neuromorphic computing community.
For institutional investors. Book with your work email.
Phosphoenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phosphoenix's valuation, stock price, and market status.
Is Phosphoenix a public or private company?
Phosphoenix is a private company.
What is the current stock price of Phosphoenix?
Phosphoenix is a private company, so its shares have no public market price. Caplight tracks Phosphoenix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phosphoenix worth (valuation)?
Valuation information for Phosphoenix is not publicly available.
Can I buy Phosphoenix stock?
Phosphoenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phosphoenix's last funding round?
Phosphoenix's most recent funding round was Early Funding on September 16, 2026.
Who are the main investors in Phosphoenix?
Key investors in Phosphoenix include European Innovation Council Fund, ROM InWest, Innovatiefonds Noord-Holland, BioGeneration Ventures.
Will Phosphoenix IPO soon?
No public IPO plans have been announced for Phosphoenix.
How can I track Phosphoenix secondary market activity?
Caplight tracks bids, offers, and trades in Phosphoenix's shares on secondary markets.